http://www.unboundmedicine.com/medline/ebm/research/efalizumabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19889301/full_citation/Efficiency_of_Biologic_Agents_in_the_Treatment_of_Moderate_to_Severe_Psoriasis_Blasco AJ, Lázaro P, Ferrándiz C, et al. 
Efficiency of Biologic Agents in the Treatment of Moderate to Severe Psoriasis. [JOURNAL ARTICLE]
Actas Dermosifiliogr 2009 Nov; 100(9):792-803.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19880554/full_citation/Efalizumab_for_subacute_cutaneous_lupus:_report_of_two_different_outcomes_Sánchez-Cano D, Callejas-Rubio JL, Ríos-Fernández R, et al. 
Efalizumab for subacute cutaneous lupus: report of two different outcomes. [JOURNAL ARTICLE]
Lupus 2009 Oct 30.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19874434/full_citation/Retrospective_analysis_of_systemic_treatments_for_psoriasis_patients_attending_a_Psocare_center_in_Florence__Relevance_of_biological_drugs_use_and_comorbidities_Prignano F, Pescitelli L, Ricceri F, et al. 
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Oct 23.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19845720/full_citation/Long_term_efficacy_of_biologics_in_the_treatment_of_psoriasis:_what_do_we_really_knowAlwawi EA, Krulig E, Gordon KB 
Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? [Journal Article]
Dermatol Ther 2009 Sep-Oct; 22(5):431-40.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19845719/full_citation/Is_there_truly_a_risk_of_lymphoma_from_biologic_therapiesDommasch E, Gelfand JM 
Is there truly a risk of lymphoma from biologic therapies? [Journal Article]
Dermatol Ther 2009 Sep-Oct; 22(5):418-30.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19842569/full_citation/A_sense_of_insecurity_Weinberg JM 
A sense of insecurity. [Editorial]
Cutis 2009 Sep; 84(3):126.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19824738/full_citation/Cutaneous_lupus_erythematosus:_issues_in_diagnosis_and_treatment_Walling HW, Sontheimer RD 
Cutaneous lupus erythematosus: issues in diagnosis and treatment. [Journal Article]
Am J Clin Dermatol 2009; 10(6):365-81.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19807998/full_citation/A_mechanism_based_classification_of_dermatologic_reactions_to_biologic_agents_used_in_the_treatment_of_cutaneous_disease:_Part_2_Bremmer M, Deng A, Gaspari AA 
A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 2. [Journal Article]
Dermatitis 2009 Oct; 20(5):243-56.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19804694/full_citation/A_mechanism_based_classification_of_dermatologic_reactions_to_biologic_agents_used_in_the_treatment_of_cutaneous_disease:_Part_1_Bremmer M, Deng A, Gaspari AA 
A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1. [Journal Article]
Dermatitis 2009 Aug; 20(4):182-92.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19800148/full_citation/[Efalizumab_induced_autoimmune_hepatitis_]Primo J, Michavila J, Jiménez I 
[Efalizumab-induced autoimmune hepatitis.] [LETTER]
Gastroenterol Hepatol 2009 Sep 30.
Full Citation | Publisher Full Text | Find Related Articles